Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
100
ESR (ERYTHROCYTE SEDIMENTATION RATE), BLOOD
Method:
Eritrosedimentation.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Primera hora:
Females < 18.00 mm
Males < 15.00 mm
Segunda hora:
Females < 38.00 mm
Males < 32.00 mm
Review:
05/03/2004
115
ERYTHROCYTE SICKLING TEST, BLOOD
Method:
Microscopic observation.
Mounting:
Delivery period:4
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
02/09/2009
118
EOSINOPHIL COUNT, NASAL MUCUS
Method:
Microscopic observation.
Mounting:
Delivery period:3
Sample:
2 Sample/s Hematological extension (2-8 ºC - Refrigerate)
1 Smear Nasopharingeous smear (2-8 ºC - Refrigerate)
Transport:
Use a slide carrier box.
Reference V.:
Negative
120
EOSINOPHILS, URINE
Method:
Microscopic observation.
Mounting:
Delivery period:1
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
05/03/2004
595
ELASTASE, PLASMA
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:12
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
28.00 - 86.00 ug/L
Review:
02/04/2009
1021
ERYTHROPOIETIN, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Do not use EDTA as an anticoagulant.
Reference V.:
4.30 - 29.00 UI/L * 1.0 = mUI/mL
1022
ESTRIOL FREE , SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
500 uL Serum (2-8 ºC - Refrigerate)
Reference V.:

Adults Females < 0.28 nmol/L * 0.288184 = ug/L
Males < 0.24 nmol/L * 0.288184 = ug/L
Gestation Females 27 Weeks 8.00 - 22.00 nmol/L * 0.288184 = ug/L
Females 28 Weeks 8.00 - 24.00 nmol/L * 0.288184 = ug/L
Females 29 Weeks 8.00 - 27.00 nmol/L * 0.288184 = ug/L
Females 30 Weeks 8.00 - 30.00 nmol/L * 0.288184 = ug/L
Females 31 Weeks 9.00 - 34.00 nmol/L * 0.288184 = ug/L
Females 32 Weeks > 10.00 nmol/L * 0.288184 = ug/L
Females 33 Weeks > 10.00 nmol/L * 0.288184 = ug/L
Females 34 Weeks > 11.00 nmol/L * 0.288184 = ug/L
Females 35 Weeks > 14.00 nmol/L * 0.288184 = ug/L
Females 36 Weeks > 16.00 nmol/L * 0.288184 = ug/L
Females 37 Weeks > 19.00 nmol/L * 0.288184 = ug/L
Females 38 Weeks > 23.00 nmol/L * 0.288184 = ug/L
Females 39 Weeks > 25.00 nmol/L * 0.288184 = ug/L
Females 40 Weeks > 26.00 nmol/L * 0.288184 = ug/L
Review:
03/07/2011
1089
EOSINOPHILIC CATIONIC PROTEIN (ECP), SERUM
Method:
Fluoroenzyme Immunoassay.
Mounting:
Delivery period:3
Sample:
500 uL Serum (2-8 ºC - Refrigerate)
Reference V.:
<= to 13.30 ug/L * 1.0 = ng/mL
1236
ETHANOL (ETHYL ALCOHOL), BLOOD
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:3
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 5 mL Total blood Sodium Citrate (2-8 ºC - Refrigerate)
Sample extraction:
Do not disinfect extraction site with ethanol.
Use sodium fluoride as an inhibitor.
Interpretation:

Mild euphoria < 10.85 mmol/L * 4.6083 = mg/dL
Fatal situations > 86.82 mmol/L * 4.6083 = mg/dL
CNS Depression 21.71 - 43.41 mmol/L * 4.6083 = mg/dL
Severe intoxication > 43.41 mmol/L * 4.6083 = mg/dL
Coma > 75.97 mmol/L * 4.6083 = mg/dL
Reference V.:
< 0.20 mmol/L * 4.6083 = mg/dL
Interpretation:

Blush, reflexes delay 10.85 - 21.71 mmol/L * 4.6083 = mg/dL
Review:
27/06/2014
1369
ENDOMISIO ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
Review:
09/07/2013
1421
EHRLICHIA CHAFFEENSIS ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:9
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/64 Titulo
Negative:
< 1/64 Titulo
R.Values:
For an adequate assessment of the result, the use of a single serum specimen should be accompanied by a series of assessments, such as: age and epidemiologic data of the patient, as well as the prevalence of disease in the area.
Review:
22/12/2008
1452
ENTAMOEBA HISTOLYTICA TOTAL ANTIBODIES, SERUM
Method:
Indirect hemagglutination.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: > 1/160 Título
Indeterminate:
1/80 1/160 Título
Negative:
< 1/80 Título
Review:
17/06/2013
1459
ECHOVIRUS ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Positive: >= to 1/80 Titulo
Negative:
< 1/80 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
19/03/2004
1464
ECHOVIRUS ANTIBODIES, IgG, CSF
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/2 Titulo
Negative:
< 1/2 Titulo
1467
ECHOVIRUS ANTIBODIES, IgM, CSF
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/2 Titulo
Negative:
< 1/2 Titulo
1470
ENTEROVIRUS RNA, BIOLOGYC LIQUID
Method:
RT-PCR.
Mounting:
Delivery period:13
Sample:
1 mL Cerebrospinal liquid (-8 ºC - Freeze)
Alt. 1 mL Pericardial fluid (-8 ºC - Freeze)
Alt. 1 g Faeces (2-8 ºC - Refrigerate)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Freeze specimen immediately.
Reference V.:
Negative
1480
ECHOVIRUS ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/20 Titulo
Negative:
< 1/20 Titulo
Review:
28/04/2009
1488
ENDOTHELIAL CELL ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/20 Titulo
Negative:
< 1/20 Titulo
1503
EPIDERMAL BASEMENT MEMBRANE ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
1560
ENDOMYSIAL ANTIBODIES, IgA, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
Review:
21/06/2013
1562
ENDOMYSIAL ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
Review:
22/10/2013
1577
EPSTEIN BARR VIRUS DNA, BLOOD/ SERUM/ BIOPSY
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 3 mL Serum (-8 ºC - Freeze)
Alt. 1 piece/s Biopsy (-8 ºC - Freeze)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
If sending blood, please refrigerate specimen.
Reference V.:
Negative
Review:
09/09/2013
1592
EPSTEIN BARR VIRUS (EBNA) ANTIBODIES, IgM, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.10 Indice
Positive:
> 1.10 Indice
Negative:
< 0.90 Indice
Review:
11/02/2014
1713
EPSTEIN BARR VIRUS (EA) ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 10.00 U/mL
Indeterminate:
10.00 - 40.00 U/mL
Positive:
> 40.00 U/mL
Review:
19/03/2004
1714
EPSTEIN BARR VIRUS (EBNA) ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 5.00 U.arb/mL
Indeterminate:
5.00 - 20.00 U.arb/mL
Positive:
> 20.00 U.arb/mL
Review:
13/11/2008
1715
EPSTEIN BARR VIRUS (VCA) ANTIBODIES, IgM, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 20.00 - 40.00 U.arb/mL
Positive:
> 40.00 U.arb/mL
Negative:
< 20.00 U.arb/mL
Review:
11/03/2010
1716
EPSTEIN BARR VIRUS (VCA) ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 20.00 U.arb/mL
Negative:
< 20.00 U.arb/mL
1746
ERYTHROCYTE ENZIMES BASIC STUDY, BLOOD
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:18
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
5 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
It's necessary to send one heparine blood tube with one EDTA blood tube.
Reference V.:
8.40 - 15.20 UI/g Hb
6.12 - 10.20 UI/g Hb
25.80 - 42.70 UI/g Hb
5.70 - 9.90 UI/g Hb
7.20 - 15.60
0.62 - 1.26 UI/g Hb
46.00 - 66.00 UI/g Hb
1750
ETHANOL (ETHYL ALCOHOL) (CREATININE), URINE
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:3
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
1950
ETHANOL (ETHYL ALCOHOL), URINE
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:4
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
05/03/2004
2186
EOSINOPHILIC CATIONIC PROTEIN (ECP), NASAL LAVAGE
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:3
Sample:
1 mL Nasal washings (2-8 ºC - Refrigerate)
R.Values:
Assess increase in eosinophil cationic protein in patients with allergic activity, compared to normal state values.
Reference V.:
Not available
2417
EDWARDS SYNDROME (CHROMOSOME 18 TRISOMY: FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:14
Sample:
3 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
27/10/2010
2472
EARLY ONSET TORSION DYSTONIA (TOR1A GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
26/03/2004
5113
EBER (EPSTEIN BARR VIRUS ENCODED RNAs) EXPRESION, BIOPSY
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:15
Sample:
1 piece/s Tissue Formaldehyde buffer (10%) (12-20 ºC - Ambient Temp.)
Reference V.:
Reported for each case
6073
ELECTRICAL CONDUCTIVITY, DRINKING WATER
Method:
Direct potenciometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic)
RD 140/2003:
< 2500.00 uS/cm a 20ºC
Review:
14/05/2011
6531
E. COLI, DRINKING WATER
Method:
Membrane filtration.
Mounting:
Delivery period:8
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
RD 140/2003:
0 UFC/100 mL
Review:
02/11/2009
6533
ENTEROBACTERIA, WATER
Method:
Membrane filtration.
Mounting:
Delivery period:5
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
07/08/2009
6534
ENDOTOXINS, DIALYSATE
Method:
Kinetic colorimetry.
Mounting:
Delivery period:5
Sample:
5 mL Dialysis water (Recipient, sterile)
Reference V.:
<= to 0.03 EU/mL
Dialysis concentrated < 0.500 EU/mL
Dialysis fluid < 0.500 EU/mL
Dialysis water < 0.250 EU/mL
Review:
24/09/2010
6536
ENTEROCOCCI, DIALYSATE
Method:
Membrane filtration (UNE-EN ISO 7899-2).
Mounting:
Delivery period:5
Sample:
300 mL Dialysis water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
30/05/2008
6538
E. COLI, DIALYSATE
Method:
Membrane filtration.
Mounting:
Delivery period:4
Sample:
300 mL Dialysis water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
02/11/2009
6556
ENTEROCOCCI, DRINKING WATER
Method:
Membrane filtration (UNE-EN ISO 7899-2).
Mounting:
Delivery period:5
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
RD 140/2003:
0 UFC/100 mL
6687
ENTEROCOCCI, WATER
Method:
Membrane filtration (UNE-EN ISO 7899-2).
Mounting:
Delivery period:5
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
30/05/2008
6688
E. COLI, WATER
Method:
Membrane filtration.
Mounting:
Delivery period:8
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
02/11/2009
6696
ELECTRICAL CONDUCTIVITY, WASTE WATER
Method:
Direct potenciometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic)
DC 130/2003:
< 6000.00 uS/cm a 20ºC
Review:
14/05/2011
6697
ELECTRICAL CONDUCTIVITY, WATER
Method:
Direct potenciometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic)
Parametric V.:
Not established.
Review:
14/05/2011
6723
ELEMENTARY ANALYSIS, SOLID
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:10
Sample:
1 g Solid (Recipient, plastic)
Reference V.:
Reported for each case
6780
ELECTRICAL CONDUCTIVITY, SWIMMING POOL WATER
Method:
Direct potenciometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic)
Parametric V.:

Déc. 23/99 23 Fev, Andalousie <= to 800.00 uS/cm a 20ºC
Review:
14/05/2011
6805
E. COLI, SWIMMING POOL WATER
Method:
Membrane filtration.
Mounting:
Delivery period:4
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
0 UFC/100 mL
6806
ENTEROBACTERIA, SWIMMING POOL WATER
Method:
Membrane filtration.
Mounting:
Delivery period:5
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
07/08/2009
6807
ENTEROCOCCI, SWIMMING POOL WATER
Method:
Membrane filtration (UNE-EN ISO 7899-2).
Mounting:
Delivery period:5
Sample:
300 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
0 UFC/100 mL
Review:
20/06/2009
6842
ELECTRIC CONDUCTIVITY, DIALYSIS WATER
Method:
Direct potenciometry.
Mounting:
Delivery period:6
Sample:
25 mL Dialysis water (2-8 ºC - Refrigerate)
Reference V.:
<= to 5.00 uS/cm a 25ºC
7039
E. COLI VEROTOXINS, CULTURE
Method:
Agglutination.
Mounting:
Delivery period:12
Sample:
1 Sample/s Culture plate (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8062
EPSTEIN BARR VIRUS (VCA) ANTIBODIES, IgG, CSF
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
8168
EPSTEIN BARR VIRUS (VCA) ANTIBODIES, IgM, CSF
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
8491
ECHINOCOCCUS GRANULOSUS/MULTILOCULARIS IgG ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.10 Indice
Positive:
> 1.10 Indice
Negative:
< 0.90 Indice
Review:
23/06/2013
8632
EVEROLIMUS, BLOOD
Method:
Polarized Immunofluorescense.
Mounting:
Delivery period:2
Sample:
2 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
3.00 - 8.00 ug/L
Toxic C.:
> 12.00 ug/L
Review:
24/03/2011
8946
EPIDERMOLYSIS BULLOSA DYSTROPHICA (COL7A1 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
8975
EPISODIC ATAXIA TYPE 1 (KCNA1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
09/06/2010
8985
ESTRONE-3-GLUCORONIDE, ORINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
3 mL 24h urine (aliquot) (2-8 ºC - Refrigerate)
Reference V.:

Folicular phase Females 5.00 - 20.00 ug/24h
Luteal phase Females 7.00 - 45.00 ug/24h
Stage IV / V Puberty 5.00 - 25.00 ug/24h
Menopause Females 5.00 - 15.00 ug/24h
Stage III Puberty 1.00 - 15.00 ug/24h
Stage I Puberty < 3.00 ug/24h
Stage II Puberty 1.00 - 8.00 ug/24h
Review:
03/07/2010
10012
EPISODIC ATAXIA TYPE 2 (CACNA1A GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
11/06/2010
10036
ENTAMOEBA HISTOLYTICA ANTIBODIES IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:18
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 1/10 Título
Negative:
< 1/10 Título
Review:
12/06/2012
10037
EPSTEIN BARR VIRUS (EA) ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/10 Titulo
Positive:
>= to 1/10 Titulo
Review:
18/04/2011
10068
EDWARDS SYNDROME (CHROMOSOME 18 TRISOMY: FISH), AMNIOTIC FLUID
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:14
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
27/10/2010
10138
ESCITALOPRAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:7
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
15.00 - 80.00 ug/L
R.Values:
Result expressed as CITALOPRAM.
Review:
24/03/2011
10152
EXTRACTION DNA, BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:2
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Not established.
Review:
18/05/2011
10153
EXTRACTION DNA, PRENATAL SAMPLE
Method:
DNA extraction using silica columns.
Mounting:
Delivery period:2
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
1 g Corial villus (12-20 ºC - Ambient Temp.)
Reference V.:
Not established.
10383
ERYTHROPOIETINE ANTIBODIES, SERUM
Method:
Radioimmunoprecipitation.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
07/09/2012
10692
ECTODERMAL ANHIDROTIC DYSPLASIA WYTH IMMUNODEFICIENCY (IKBKG GENE: SEQ.), BLOOD
10693
ECTODERMAL DYSPLASIA HYPOHIDROTIC (EDA GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10694
ECTODERMAL DYSPLASIA HYPOHIDROTIC (EDA GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10708
EHLERS-DANLOS CLASSIC SYNDROME (COL5A1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
15 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10709
EHLERS-DANLOS CLASSIC SYNDROME (COL5A2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
15 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10710
EHLERS-DANLOS VASCULAR SYNDROME (COL3A1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
15 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
04/05/2014
10711
EHLERS-DANLOS VASCULAR SYNDROME (COL3A1 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10712
EPIDERMOLYSIS BULLOSA DYSTROPHICA (COL7A1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10713
EPILEPSY FAMILIAL TEMPORAL LOBE1 (LGI1 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:75
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10714
EPILEPSY GENERALIZED WITH FEBRILE SEIZURES PLUS (GABRG2 GENE: SEQ.), BLOOD
10723
EXOSTOSES MULTIPLE HEREDITARY (EXT1 and EXT2 GENES: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10739
EPISODIC ATAXIA TYPE 2 (CACNA1A GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10798
EXOSTOSE MULTIPLE HEREDITARY I (EXT1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10864
EXPRESION CYCLIN D1, BLOOD
Method:
Real Time RT-PCR.
Mounting:
Delivery period:21
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Negative
10956
EPIDERMOLISIS BULLOSA A. DTE (COL7A1 EXONS 73,74,75), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10985
ECTODERMAL HYPOHIDROTIC DYSPLASIA (EDA GENE), AMNIOTIC F.
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
11089
EMERY-DREIFUSS RECESSIVE MUSCULAR DYSTROPHY 3 (LMNA GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11114
EXOSTOSE MULTIPLE HEREDITARY II (EXT2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11127
EPILEPSY PYRIDOXINE-DEPENDENT (ALDH7A1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11181
EDWARDS SYNDROME (CHROMOSOME 18 TRISOMY: FISH), CHORIONIC VILLI
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:18
Sample:
0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
Review:
13/10/2014
11222
ELASTASE ANTIBODIES, PLASMA
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:16
Sample:
1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: > 1.00 Indice
Negative:
<= to 1.00 Indice
11567
EPSTEIN BARR VIRUS DNA QUANTIFICATION (VIRAL LOAD), BIOLOGICAL FLUID
11662
EHLERS-DANLOS CLASSIC SYNDROME (COL1A1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11665
EXOSTOSE MULTIPLE HEREDITARY I (EXT1 GENE: KNOWN M.), BLOOD
11689
EXOME STUDY (NEXT GENERATION SEQUENCING), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:75
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11939
ESLICARBAMAZEPINE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:6
Sample:
500 uL Serum (2-8 ºC - Refrigerate)
14322
EHLERS-DANLOS SYNDROME (TNXB GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14670
EHLERS-DANLOS SYNDROME (TNXB GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14748
ECHINOCOCCUS GRANULOSUS/MULTILOCULARIS DNA, CSF
Method:
Polymerase chain reaction.
Mounting:
Delivery period:17
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
14763
ESTRONE, SERUM 60 m
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Serum 60m (2-8 ºC - Refrigerate)
Reference V.:
Not available
14783
EHRLICHIA CANIS ANTIBODIES IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative: < 1/20 Titulo
Positive:
>= to 1/20 Titulo
14784
EHRLICHIA CANIS ANTIBODIES IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 1/20 Titulo
Negative:
< 1/20 Titulo
14923
ENTEROHEMORRAGIC E. COLI IDENTIFICATION, CULTURE
Method:
Polymerase chain reaction.
Mounting:
Delivery period:8
Sample:
1 Sample/s Colonies (pure culture) (2-8 ºC - Refrigerate)
Reference V.:
Negative
14942
EPSTEIN BARR VIRUS DNA, AMNIOTIC FLUID
Method:
Real Time PCR.
Mounting:
Delivery period:5
Sample:
3 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Reference V.:
Negative
14948
EPISODIC KINESIGENIC DYSKINESIA TYPE 2 (PRRT2 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14981
EPISODIC ATAXIA TYPE 2 (CACNA1A GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14982
EPISODIC ATAXIA TYPE 2 (CACNA1A GENE), CHORIONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
14994
EPILEPTIC ENCEPHALOPTAHY INFANTILE (SPTAN1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14995
EPILEPTIC ENCEPHALOPATHY EARLY INFANTIL (SPTAN1 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14998
EPILEPTIC ENCEPHALOPATHY EARLY INFANTIL (SPTAN1 GENE), C. VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15253
ECHINOCOCCUS GRANULOSUS ANTIBODIES IgG (CONFIRMATION), SERUM
Method:
Immunoblot.
Mounting:
Delivery period:13
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
15265
ERYTHROCYTE MEMBRANE PROTEINS, BLOOD
Method:
Polyacriyamide gel electrophoresis (SDS-PAGE).
Mounting:
Delivery period:185
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
5 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
It's necessary to send one heparine blood tube with one EDTA blood tube.
Reference V.:
Reported for each case
15388
EPILEPSY FAMILIAL FOCAL (DEPDC5 GENE: SEQUENCING), BLOOD
15389
EPILEPSY FAMILIAL FOCAL (DEPDC5 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15390
EPILEPTIC ENCEFALOPATHY EARLY INFANTILE (DNM1 GENE: NGS), BLOOD
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15391
EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE (DNM1 GENE: K. MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15414
ECTODERMAL ANHIDROTIC DYSPLASIA (EDAR GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15433
EPILEPSY MIOCLONIC PROGRESSIVE 2 A (EPM2A GENE: SEQUENCING), BLOOD
15712
ESTRONE, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Males 33.30 - 292.67 pmol/L * 0.27027 = pg/mL
Postmenopause Females 37.37 - 154.29 pmol/L * 0.27027 = pg/mL
Premenopause Females 58.09 - 506.16 pmol/L * 0.27027 = pg/mL
15713
ESTRONE, SERUM Baseline
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:3
Sample:
1 mL Baseline serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Males 33.30 - 292.67 pmol/L * 0.27027 = pg/mL
Postmenopause Females 37.37 - 154.29 pmol/L * 0.27027 = pg/mL
Premenopause Females 58.09 - 506.16 pmol/L * 0.27027 = pg/mL
15720
ETHOSUXIMIDE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
40.00 - 100.00 mg/L * 7.084 = µmol/L
15817
ERYTHROCYTOSIS FAMILIAL 2 (R200W and H191D MUTATIONS: VHL GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15900
ECA GENE (In/Del POLYMORPHISM), BLOOD
Method:
Polymerase chain reaction.
Mounting:
Delivery period:15
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case